Going Back to the Well in a Sector That’s Working
After years of underperformance, biotech is finally catching a nice bid. Here’s my strategy on a name showing promise.
Bearish Bets: Earnings Were Not Kind to Every Stock
These names fell hard post earnings and look to have more downside action in store.
The Yield Trap Investors Keep Falling For
A high dividend yield can look like a ticket to lasting retirement income, until the cut arrives. Before rushing into a high-yield name, ask yourself three questions.
Embrace the Tough Market, It’s Making You a Better Trader
Here’s how to take advantage of down times in the market, to expect cycles of bullish and bearish periods, and become a better trader.
30 Signals Across the Portfolio’s 10 Themes and Strategies
Let’s scan through the headlines for the stories of the week that speak to our Pro Portfolio holdings.
Weekly Roundup: What We’re Watching as Markets Get Jiggy
We locked in massive gains on two positions and added to two beaten-down holdings.
Adding to Our Microsoft Position on Weakness
We’ll take advantage of the improved risk-to-reward tradeoff, and longer-term prospects.
VIDEO: Our Take on the Latest OpenAI IPO News
Let’s also follow up on our updated game plan for Palantir, and check in on Microsoft.
Make or Break Day for Brokers, Danger on Chart, Mag 7 Down
Here’s why good economic data is weighing down stocks, Russell’s rebalancing will make winners and losers and the chart looks … perilous.